ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis

Amgen · 2019
ClinicalTrials.gov · Datasets · License: Public Domain · 2019
Open Source ↗
atopicdermatitisdermatitisdermatologyinflammationskin
atopic dermatitis, eczema, tezepelumab, dermatology, dermatitis, inflammation, skin, moderate dermatitis, severe dermatitis, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 910387
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.